FilingReader Intelligence

Zhifei Bio's pneumonia vaccine achieves positive trial results

March 27, 2025 at 08:16 PM UTCBy FilingReader AI

Chongqing Zhifei Biological Products (SZSE:300122) reported that its subsidiary, Zhifei Green Bamboo Pharmaceutical, has received the Phase III clinical trial summary report for its 15-valent pneumococcal conjugate vaccine. The vaccine aims to prevent invasive diseases caused by 15 serotypes of Streptococcus pneumoniae. The trial results demonstrate good immunogenicity and safety, achieving all pre-set goals and meeting standards for immunogenicity and safety assessment.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Chongqing Zhifei Biological Products publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →